Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

This study has been completed.

Sponsored by:	Alberta Cancer Board
Information provided by:	Alberta Cancer Board
ClinicalTrials.gov Identifier:	NCT00314522

Purpose

This study performed a retrospective analysis of patient images to develop software in determining dose delivered for each fraction treatment.

Condition
Healthy

Study Type:	Observational
Study Design:	Retrospective
Official Title:	Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Further study details as provided by Alberta Cancer Board:

Estimated Enrollment:	5
Study Start Date:	September 2005
Estimated Study Completion Date:	March 2006

Eligibility

Criteria

Inclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00314522

Locations

Sponsors and Collaborators

Alberta Cancer Board

Investigators

Principal Investigator:

Gino Fallone, PhD

Alberta Cancer Board

More Information

Study ID Numbers:	EX-0003
Study First Received:	April 11, 2006
Last Updated:	September 22, 2008
ClinicalTrials.gov Identifier:	NCT00314522
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Healthy

ClinicalTrials.gov processed this record on January 16, 2009